The Federal Trade Commission's Role in the Oversight of Drug Companies episode artwork

EPISODE · May 20, 2024 · 15 MIN

The Federal Trade Commission's Role in the Oversight of Drug Companies

from JAMA Clinical Reviews

The Federal Trade Commission's (FTC) oversight role in the pharmaceutical market is critical to the health of patients and the health care system. Aaron Kesselheim, MD, JD, MPH, and JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, discuss the FTC's policies and legal actions related to alleged misconduct, consolidation, and anticompetitive behavior in the pharmaceutical market. Related Content: Federal Trade Commission Actions on Prescription Drugs, 2000-2022

Episode metadata supplied by the publisher feed · Published May 20, 2024

Embed this episode

Ready to play

The Federal Trade Commission's Role in the Oversight of Drug Companies

0:00 15:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Clinical Reviews?

This episode is 15 minutes long.

When was this JAMA Clinical Reviews episode published?

This episode was published on May 20, 2024.

Can I download this JAMA Clinical Reviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!